In an important new study, Chinese researchers have discovered the previously unrecognized role of alternative splicing of the DOC2A gene in ...
Mars-like shock and chemical stress reveal ribonucleoprotein condensates as a key survival mechanism in yeast. Life on Mars, ...
Cholera remains a major global public health challenge, with an estimated 1.3 to 4 million cases and tens of thousands of ...
Morning Overview on MSN
Frozen mammoth discovery shatters what scientists knew about ancient RNA
When scientists sliced into a block of Siberian permafrost and pulled out a woolly mammoth nicknamed Yuka, they expected to ...
Disruption of alternative splicing can generate abnormal mRNA variants, producing nonfunctional proteins or triggering ...
AZoLifeSciences on MSN
Synthetic RNA platform converts viral replication into detectable cellular signals
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration with Alida ...
Adjusted EBITDA -- $1.1 million for the period, compared to an adjusted loss of $1.4 million in the same quarter last year.
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
Aperture Therapeutics, a biotechnology company pioneering next-generation precision medicines for neurodegenerative diseases, today announced the advancement of its matrix metalloproteinase-9 (MMP9) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback